Hyundai   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Seoul Korea, Republic of (1967)
Status: No NME R&D (1967)

Organization Overview

First Clinical Trial
2010
NCT02378194
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Hyundai Hope On Wheels | Hyundai Pharm | Hyundai Pharmaceutical Co., LTD.